OSTX insider transaction filings
OS Therapies Inc — 27 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-13. Screen OSTX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for OSTX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — OS Therapies Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-13 | 4 | McKean-Dieser Avril Suzette — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Search Theodore F. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Ciccio John — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Acevedo Christopher P. — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Romness Paul A. — President and CEO, Director | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Galzahr Karim — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4/A | Romness Paul A. — President and CEO, Director | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Jarry Olivier Roger — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | PETIT ROBERT — See Remarks | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Search Theodore F. — Director | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Romness Paul A. — President and CEO, Director | Grant/award (A): 1,950,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Galzahr Karim — Director | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Ciccio John — Director | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Acevedo Christopher P. — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | McKean-Dieser Avril Suzette — Director | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Jarry Olivier Roger — Director | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | PETIT ROBERT — See Remarks | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | Auerbach Shalom Einodmil LLC | Holdings only — no transactions reported | EDGAR |
| 2025-05-09 | 4 | Auerbach Shalom — 10% owner Einodmil LLC — 10% owner | Sale (S): 82,000 @ $2.00 | EDGAR |
| 2025-04-11 | 4 | Auerbach Shalom — 10% owner Einodmil LLC — 10% owner | Sale (S): 50,012 @ $1.35 · Sale (S): 10,000 @ $1.39 | EDGAR |
| 2025-02-28 | 4 | Auerbach Shalom — 10% owner Einodmil LLC — 10% owner | Other (J): 225,000 @ $1.64 | EDGAR |
| 2025-02-28 | 4 | Romness Paul A. — President and CEO, Director, 10% owner | Other (J): 225,000 @ $0 | EDGAR |
| 2025-02-18 | 4 | Auerbach Shalom — 10% owner Einodmil LLC — 10% owner | Sale (S): 100,000 @ $2.84 | EDGAR |
| 2025-01-17 | 4 | Auerbach Shalom — 10% owner Einodmil LLC — 10% owner | Sale (S): 16,720 @ $6.74 | EDGAR |
| 2025-01-14 | 4 | Auerbach Shalom — 10% owner Einodmil LLC — 10% owner | Conversion (C): 23,371 · Conversion (C): 633,980 · Conversion (C): 27,486 · Conversion (C): 270,465 · Conversion (C): 53,468 · Conversion (C): 131,472 · +18 more | EDGAR |
| 2024-08-06 | 4 | Search Theodore F. — Director | Conversion (C): 101,765 · Conversion (C): 266,306 · Conversion (C): 30,264 | EDGAR |
| 2024-08-06 | 4 | Ciccio John — Director | Conversion (C): 101,765 · Conversion (C): 266,306 · Conversion (C): 30,264 | EDGAR |
Recent 8-K events — OS Therapies Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2026-07-07 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OSTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →